Biodexa Pharmaceuticals Plc (BDRX) income statement
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)
Close on Nov 18, 2026Market cap $4.60MP/E –Yield –
Biodexa Pharmaceuticals Plc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 2.41
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 116.3%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?